AB
Acorn Bioventures, L.P. cut its KPTI stake below 5%
Acorn Bioventures, L.P. reported owning 4.5% of Karyopharm Therapeutics Inc. (KPTI) (1,021,668 shares) in a Schedule 13G filed Oct 8, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 8, 2026
- Source
- Schedule 13G